Diabetes/pre-diabetes
Conditions
Interventions
Use of the smartwatch, use of the mobile application for self-monitoring health data, and advice by doctors (video call at 1 month and 3 months from start), pharmacists (weekly chatting for patients w
Sponsors
Nagoya Station Clinic
Milliman Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. With HbA1c 7.0% or more and 8.0% or less 2. Aged 25 years or more and less than 75 (male and female) 3. Daily smartphone user 4. Wishing to participate to the program
Exclusion criteria
Exclusion criteria: 1. Having comorbidity of severe hepatic dysfunction (3 times or more of upper limit of reference value for AST or ALT), hemodialysis, or comorbidity of cancer 2. Receiving treatment with insulin 3. In pregnancy or planning to get pregnant 4. Being restricted exercise 5. Having cognitive dysfunction 6. Having serious cardiovascular diseases (myocardial infarct, angina, serious arrhythmia, hypertension with a systolic blood pressure 180 mmHg or more or with a diastolic blood pressure 110 mmHg or more) 7. Being deemed inappropriate to participate to this study by his/her primary physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hemoglobin (Hb) A1c at 12 and 24 weeks from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in body weight (body mass index) at 12 and 24 weeks from baseline 2. Change in abdominal girth at 12 and 24 weeks from baseline 3. Change in blood pressure at 12 and 24 weeks from baseline 4. Change in blood test values (fasting blood glucose, total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol) at 12 and 24 weeks from baseline 5. Change in lifestyle behavior and depression status based on questionnaires at 24 weeks from baseline 6. Monthly change in exercise behavior based on recorded number of steps | — |
Countries
Japan
Contacts
Public ContactKohei Sasaki
Sugi Pharmacy Co., Ltd. Corporate Planning division
Outcome results
None listed